Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation ESC 2025

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

Presenter: Mårten Falkenberg, Joakim Nordanstig

August 31, 2025

Presentation Cardiovascular Interventions 2024

AGENT DCB: Device and Data

Presenter: Paul S. Teirstein

November 11, 2024

Presentation Complex Coronary Cases 2023

In-Stent Restenosis: Update and Devices

Presenter: Melissa Chang

June 16, 2023

Presentation JIM 2018

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

Presenter: Michael Laule

February 23, 2018

Presentation JIM 2018

Embolized Devices and Retrieval

Presenter: Giovanni Esposito

February 21, 2018

Presentation JIM 2017

BRS - A “Stillborn” Device!

Presenter: Davide Capodanno

February 08, 2017

Presentation CHIP Florida 2017

Treatment of Calcific Coronary Arteries: Device and Data Updates

Presenter: Martin B. Leon

January 21, 2017

Presentation JIM 2016

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Presenter: Azeem Latib

February 10, 2016

Presentation

Event Rates in RCTs Evaluating Cardiovascular Interventions and Devices

Presenter: KD. Mahmoud

June 09, 2015

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Future BRS Directions: New Platforms and Devices to Address Current Technical Limitations

Presenter: Alexandre Abizaid, Helio R Figueira, Jamil Abdalla Saad

September 13, 2014

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

Presentation BRS 2014

The Abbott BVSDevice and Iterations

Presenter: Richard J Rapoza

July 25, 2014

Presentation BRS 2014

DREAMS: Unique Properties, Device Iterations and Outcomes

Presenter: Michael Haude

July 25, 2014

Presentation BRS 2014

DESolve ® Device Description and Clinical Results

Presenter: Stefan Verheye

July 25, 2014

Presentation BRS 2014

(Non)-Invasive Imaging of Metallic Bioresorbable DevicesDreams Experience

Presenter: Jacques Koolen

July 25, 2014

Presentation TCT 2013

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Presenter: Michael Joner

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Presenter: Erwin Blessing

October 31, 2013

Advertisement

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

AGENT DCB: Device and Data

In-Stent Restenosis: Update and Devices

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

Embolized Devices and Retrieval

BRS - A “Stillborn” Device!

Treatment of Calcific Coronary Arteries: Device and Data Updates

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Event Rates in RCTs Evaluating Cardiovascular Interventions and Devices

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Future BRS Directions: New Platforms and Devices to Address Current Technical Limitations

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

The Abbott BVSDevice and Iterations

DREAMS: Unique Properties, Device Iterations and Outcomes

DESolve ® Device Description and Clinical Results

(Non)-Invasive Imaging of Metallic Bioresorbable DevicesDreams Experience

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content